Metraipolis › archive › dc_6cdfaa64fc7d
Survival benefits of immunotherapy combined with chemoradiotherapy in metastatic colorectal cancer: an analysis based on data from the SEER database — Europe PMC PMID:42058112
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42058112
- DOI
- 10.1515/med-2026-1416
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T04:15:34.622Z
- SHA-256 of the archived text
88b180882f388e6872d1adf7629a3d53a915f1800801d4e6915dbde45d907aca- Stable URL of this page
https://metraipolis.com/documento/dc_6cdfaa64fc7d
How to cite
Survival benefits of immunotherapy combined with chemoradiotherapy in metastatic colorectal cancer: an analysis based on data from the SEER database — Europe PMC PMID:42058112 — Europe PMC (en), https://europepmc.org/article/MED/42058112 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6cdfaa64fc7d (Metraipolis archive dc_6cdfaa64fc7d, sha256 88b180882f388e6872d1adf7629a3d53a915f1800801d4e6915dbde45d907aca)
BibTeX
@misc{dc6cdfaa64fc7d,
title = {Survival benefits of immunotherapy combined with chemoradiotherapy in metastatic colorectal cancer: an analysis based on data from the SEER database — Europe PMC PMID:42058112},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42058112},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6cdfaa64fc7d; sha256 88b180882f388e6872d1adf7629a3d53a915f1800801d4e6915dbde45d907aca},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42058112. Agents can read the archived copy with the MCP tool read_document.